Anlon Healthcare — 360° view

Anlon Healthcare, a company in the Pharmaceuticals industry, reported revenue of ₹106 crore and net profit of ₹17 crore for the September 2026 quarter.

Anlon Healthcare (NSE: AHCL) closed at ₹25.17 on 20 Nov 2026, up 61.0% over the past year. Its market capitalisation is ₹1,338 crore and it trades at 37.5 times earnings.

Share price
₹25.17 (20 Nov 2026)
Market cap
₹1,338 Cr (20 Nov 2026)
P/E
37.49 (20 Nov 2026)
Revenue
₹106 Cr (September 2026 quarter)
Net profit
₹17 Cr (September 2026 quarter)
ROCE
20.8% (FY26)
ROE
18.4% (FY26)
Book value
₹4.84 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹37.24 / ₹10.37 (20 Nov 2026)
1-year return
61.0% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: AHCL

Incorporated in 2013, Anlon Healthcare Limited is a chemical manufacturing company engaged in the manufacturing of Pharma Intermediates and active pharmaceutical ingredients (APIs).

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.